Literature DB >> 16362898

T cells require tumor necrosis factor-alpha to provide protective immunity in mice infected with Histoplasma capsulatum.

George S Deepe1, Reta S Gibbons.   

Abstract

We examined whether neutralization of tumor necrosis factor (TNF)-alpha after intranasal exposure of mice to Histoplasma capsulatum was necessary for control of primary or secondary infection. All mice given monoclonal antibody to TNF-alpha on the day of infection or on day 3 after infection died. When antibody was administered on day 5 after infection, 60% of mice with primary infection died, whereas none with secondary infection did. Antibody treatment on day 7 after infection produced a transiently higher fungal burden. Because optimal clearance required TNF-alpha after the onset of infection, we hypothesized that it may regulate T cell function. Lung CD3+ cells were the dominant population of TNF-alpha-producing cells (approximately 40%-70%). Neutralization of this cytokine decreased the number of memory T cells but not the number of activated, proliferating, or interferon-gamma-producing cells. T cells from infected, TNF-alpha-neutralized mice failed to protect T cell-deficient mice. The absence of TNF-alpha induces a defect in T cell-mediated protection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362898      PMCID: PMC1390767          DOI: 10.1086/498981

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Tumor necrosis factor-alpha plays a role in host defense against Histoplasma capsulatum.

Authors:  J G Smith; D M Magee; D M Williams; J R Graybill
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

2.  Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans.

Authors:  G B Huffnagle; G B Toews; M D Burdick; M B Boyd; K S McAllister; R A McDonald; S L Kunkel; R M Strieter
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

3.  Activation of human macrophage fungistatic activity against Histoplasma capsulatum upon adherence to type 1 collagen matrices.

Authors:  S L Newman; L Gootee; C Kidd; G M Ciraolo; R Morris
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

4.  Modulation of immune responses in murine pulmonary histoplasmosis.

Authors:  R Allendoerfer; G P Biovin; G S Deepe
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

5.  Evolution of the primary immune response to Histoplasma capsulatum in murine lung.

Authors:  J A Cain; G S Deepe
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

6.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

7.  Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice.

Authors:  B A Wu-Hsieh; G S Lee; M Franco; F M Hofman
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  Role of CD8+ T cells in host resistance to systemic infection with Histoplasma capsulatum in mice.

Authors:  G S Deepe
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

9.  IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma.

Authors:  P Zhou; M C Sieve; J Bennett; K J Kwon-Chung; R P Tewari; R T Gazzinelli; A Sher; R A Seder
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

10.  Induction of apoptosis in mature T cells by tumour necrosis factor.

Authors:  L Zheng; G Fisher; R E Miller; J Peschon; D H Lynch; M J Lenardo
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

View more
  16 in total

Review 1.  Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets.

Authors:  Pauline L Martin; Peter J Bugelski
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor.

Authors:  Chad A Rappleye; Linda Groppe Eissenberg; William E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

Review 3.  Cytokines and the regulation of fungus-specific CD4 T cell differentiation.

Authors:  Vanessa Espinosa; Amariliz Rivera
Journal:  Cytokine       Date:  2011-11-30       Impact factor: 3.861

Review 4.  How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.

Authors:  Steven T Denham; Morgan A Wambaugh; Jessica C S Brown
Journal:  J Mol Biol       Date:  2019-05-09       Impact factor: 5.469

Review 5.  The role of cytokines and chemokines in Histoplasma capsulatum infection.

Authors:  Danielle N Kroetz; George S Deepe
Journal:  Cytokine       Date:  2011-08-26       Impact factor: 3.861

6.  Prostaglandins D2 and E2 have opposite effects on alveolar macrophages infected with Histoplasma capsulatum.

Authors:  Priscilla A T Pereira; Patrícia A Assis; Morgana K B Prado; Simone G Ramos; David M Aronoff; Francisco W G de Paula-Silva; Carlos A Sorgi; Lúcia H Faccioli
Journal:  J Lipid Res       Date:  2017-12-07       Impact factor: 5.922

7.  Tumor necrosis factor-alpha antagonism by the murine tumor necrosis factor-alpha receptor 2-Fc fusion protein exacerbates histoplasmosis in mice.

Authors:  George S Deepe
Journal:  J Interferon Cytokine Res       Date:  2007-06       Impact factor: 2.607

8.  TNF-alpha antagonism generates a population of antigen-specific CD4+CD25+ T cells that inhibit protective immunity in murine histoplasmosis.

Authors:  George S Deepe; Reta S Gibbons
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

Review 9.  Histoplasma capsulatum, lung infection and immunity.

Authors:  Michael C Horwath; Roger A Fecher; George S Deepe
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

10.  Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Sailatha Ravi; Sandra Macias; Mattie L Young; Michal A Olszewski; Chad Steele; Floyd L Wormley
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.